RE: Seems like ..5 May 2022 17:48
Hey @Fornef. What I mean is, lets say Merck are keen to buy at 150p and the 4D BoD are in agreement. If the share price is at 100p when this news is delivered to shareholders then they may not vote for it - not too much gain for a VERY long period of shareholder pain! If the share price is at 37p, as it is now, then I suspect most shareholders would (perhaps reluctantly in some cases) agree to a deal at 150p. Its therefore potentially beneficial for the deal to be accepted if the share price is as low as possible upon announcement.
All speculation of course, there may be no sale, though I would at least expect updates on Blautix and Oxford Finance shortly.
Personally, I DO think buy out talks are happening behind closed doors, there is no good reason for the radio silence from the company if that's not the case.